Catalyst Wire Dossier Catalyst Wire Dossier

MDX2003

· ModeX Therapeutics (an OPKO Health company)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDX2003, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma [Phase 1, Phase 2]

See pricing